Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Bluesky CEO Jay Graber will step aside

March 9, 2026

RODE Releasing Compact Software-Based RODECaster Video Core Console; More Info at B&H

March 9, 2026

MAX Power Announces $20 Million Brokered Offering

March 9, 2026

Artificial intelligence residency at Calgary Public Library raises some eyebrows

March 9, 2026

Emergenetics Leadership Workshops Help Organizations Build Stronger Teams

March 9, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home ยป $26.29 Bn Biochips Markets – Forecasts from 2025 to 2030: Opportunities in Diagnostics, Drug Discovery, and Personalized Medicine, with Significant Potential in Emerging Markets
Press Release

$26.29 Bn Biochips Markets – Forecasts from 2025 to 2030: Opportunities in Diagnostics, Drug Discovery, and Personalized Medicine, with Significant Potential in Emerging Markets

By News RoomDecember 5, 20254 Mins Read
.29 Bn Biochips Markets – Forecasts from 2025 to 2030: Opportunities in Diagnostics, Drug Discovery, and Personalized Medicine, with Significant Potential in Emerging Markets
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) — The “Biochips Market – Forecasts from 2025 to 2030” report has been added to ResearchAndMarkets.com’s offering.

The Biochips Market is set to expand from USD 14.590 billion in 2025 to USD 26.292 billion by 2030, with a 12.50% compound annual growth rate (CAGR).

The biochips market is witnessing significant growth, driven by the technology’s ability to perform rapid, simultaneous biological experiments on a compact microarray platform. Unlike electronic microchips, biochips are non-electronic devices equipped with millions of biosensors that detect analytes such as enzymes, proteins, DNA, or antibodies.

These microreactors enable applications like disease diagnostics, drug discovery, genomics, proteomics, and agriculture, as well as specialized functions such as tracking, medical sensing (e.g., BP, glucose, oxygen), and personalized medicine. Since 2023, the market has been propelled by rising incidences of life-threatening disorders, an aging population susceptible to conditions like cancer, and increasing demand for tailored healthcare solutions.

Key growth drivers include expanding global healthcare expenditure and heightened government funding for biotechnology R&D. These investments support advancements in biochip technologies, enhancing their precision and applicability across diverse fields. The surge in chronic diseases and the need for rapid diagnostics further boost demand, particularly for DNA chips, protein chips, and lab-on-chip systems. Biotechnology and pharmaceutical companies, hospitals, diagnostic centers, and academic institutes are key end-users, leveraging biochips for innovative research and patient care. However, challenges such as high costs, limited consumer awareness, and privacy concerns related to biological data usage pose restraints. These hurdles necessitate ongoing education and robust data protection measures to sustain market growth.

Geographically, North America and Europe lead due to advanced healthcare infrastructures and significant R&D investments, while Asia-Pacific is experiencing rapid expansion driven by increasing healthcare spending and rising prevalence of chronic diseases. The Middle East, Africa, and South America show emerging potential as awareness and infrastructure develop. Regional regulatory frameworks influence market dynamics, with stringent standards in developed markets ensuring product safety but increasing compliance costs.

Market segmentation highlights types (DNA chips, protein chips, lab-on-chip, others), applications (drug discovery, disease diagnostics, genomics, proteomics, agriculture, others), and end-users (biotech/pharma, hospitals, research institutes, others). Competitive analysis underscores major players’ focus on innovation, with recent deals and investments enhancing product portfolios. Companies are prioritizing advanced sensor technologies and scalable manufacturing to meet growing demand. Market insights, derived from industry reports and stakeholder inputs, utilize comprehensive methodologies, including lifecycle analysis and data triangulation, to forecast trends. Visual aids like charts enhance stakeholder understanding of market dynamics.

From 2023 to 2025, the biochips market is poised for robust growth, fueled by technological advancements, rising healthcare needs, and expanding applications. Addressing cost barriers, awareness gaps, and privacy concerns will be critical to unlocking the market’s full potential, positioning biochips as a cornerstone of modern biotechnology and personalized medicine.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Key Attributes:

Report Attribute Details
No. of Pages 146
Forecast Period 2025 – 2030
Estimated Market Value (USD) in 2025 $14.59 Billion
Forecasted Market Value (USD) by 2030 $26.29 Billion
Compound Annual Growth Rate 12.5%
Regions Covered Global

Companies Featured

  • Abbott Laboratories
  • Revvity, Inc.
  • Standard BioTools Inc.
  • Randox Laboratories
  • Thermo Fisher Scientific
  • Bio Rad Laboratories
  • Illumina Inc.
  • Agilent Technologies
  • GE Healthacre
  • Cepheid Inc,
  • F. Hoffmann-La Roche AG

Segmentation

By Type

  • DNA Chip
  • Protein Chip
  • Lab-on-Chip
  • Cell-Based & Tissue Chips

By Application

  • Drug Discovery and Development
  • Disease Diagnostics
  • Genomics
  • Proteomics
  • Agriculture
  • Environmental Testing
  • Others

By End-User

  • Biotech & Pharma
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes
  • CROs & Government Labs

By Geography

North America

  • United States
  • Canada
  • Mexico

South America

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Middle East & Africa

Asia-Pacific

  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

For more information about this report visit https://www.researchandmarkets.com/r/cmihw6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

RODE Releasing Compact Software-Based RODECaster Video Core Console; More Info at B&H

MAX Power Announces $20 Million Brokered Offering

Emergenetics Leadership Workshops Help Organizations Build Stronger Teams

Sherry Cummings, CEO of Gryphon Healthcare, Named One of the Top 50 Women to KNOW in Texas

Gubernatorial Candidate Keisha Lance Bottoms to Join ‘The Jay Walker Podcast’ for Exclusive Interview This Thursday, March 12th

DRVN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Driven Brands Holdings (DRVN) Investors of Securities Class Action Deadline on May 8, 2026

Novonesis named a Great Employer to Work For in North Carolina

Building on Taco Tuesday, Taco John’s Expands Daily Deals to Deliver Even More Value

LGI Homes Returns to Seagoville, TX, with the Grand Opening of Edmonds Ranch

Editors Picks

RODE Releasing Compact Software-Based RODECaster Video Core Console; More Info at B&H

March 9, 2026

MAX Power Announces $20 Million Brokered Offering

March 9, 2026

Artificial intelligence residency at Calgary Public Library raises some eyebrows

March 9, 2026

Emergenetics Leadership Workshops Help Organizations Build Stronger Teams

March 9, 2026

Latest News

Sherry Cummings, CEO of Gryphon Healthcare, Named One of the Top 50 Women to KNOW in Texas

March 9, 2026

Everything from the last week of everything is gambling now

March 9, 2026

Gubernatorial Candidate Keisha Lance Bottoms to Join ‘The Jay Walker Podcast’ for Exclusive Interview This Thursday, March 12th

March 9, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version